|

100gm HDAA Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Arkansas1

Indications

  • Plasma Cell Disorder1
  • Cancer1

Little Rock, Arkansas1 trial

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

University of Arkansas for Medical Sciences

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.